Double maintains 1 strategies that include ALDX - Aldeyra Therapeutics, Inc.
Current Value
$3.981 Year Return
Current Value
$3.981 Year Return
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| SLF | -0.03% | $37.55B | +35.64% | 3.69% |
| SJM | -0.04% | $10.96B | -6.96% | 4.20% |
| FLO | -0.04% | $3.42B | -26.77% | 5.97% |
| REYN | 0.05% | $4.58B | -20.94% | 4.24% |
| DOGZ | 0.06% | $162.32M | -27.35% | 0.00% |
| UTZ | 0.06% | $1.13B | -19.50% | 1.85% |
| FRO | -0.07% | $3.67B | -34.81% | 8.08% |
| WMK | -0.07% | $2.02B | +20.59% | 1.85% |
| LION | 0.11% | $1.65B | -30.69% | 0.00% |
| FMX | 0.11% | $21.29B | -2.65% | 4.34% |
| SYPR | -0.13% | $46.42M | +9.19% | 0.00% |
| DAO | -0.13% | $269.33M | +135.25% | 0.00% |
| PAC | 0.14% | $10.05B | +51.64% | 0.00% |
| FSLR | -0.15% | $17.48B | -24.81% | 0.00% |
| CHT | -0.15% | $36.18B | +21.02% | 3.14% |
| CTAS | -0.16% | $90.57B | +27.39% | 1.23% |
| CM | -0.17% | $66.43B | +48.08% | 3.83% |
| KHC | -0.18% | $31.49B | -16.84% | 6.00% |
| AU | -0.19% | $23.06B | +79.47% | 2.25% |
| GOGL | -0.20% | $1.48B | -46.62% | 10.48% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MCK | -29.40% | $90.90B | +24.44% | 0.39% |
| KR | -27.20% | $47.17B | +41.48% | 1.81% |
| COR | -23.26% | $57.24B | +32.73% | 0.74% |
| EXC | -21.00% | $43.82B | +25.72% | 3.63% |
| CME | -20.97% | $99.25B | +39.75% | 3.87% |
| DUK | -20.60% | $92.39B | +19.10% | 3.55% |
| CBOE | -20.25% | $24.29B | +35.36% | 1.09% |
| ED | -20.11% | $36.31B | +13.27% | 3.35% |
| PGR | -19.98% | $154.94B | +25.19% | 1.87% |
| KO | -19.52% | $308.49B | +13.49% | 2.78% |
| TEF | -19.47% | $30.02B | +27.27% | 6.13% |
| UL | -19.04% | $150.91B | +12.15% | 3.19% |
| FMS | -18.33% | $16.88B | +50.16% | 2.85% |
| WCN | -17.98% | $48.03B | +6.17% | 0.67% |
| NGG | -17.22% | $72.92B | +29.56% | 4.29% |
| RSG | -17.22% | $76.46B | +26.67% | 0.94% |
| VRSK | -16.64% | $43.78B | +14.90% | 0.54% |
| XEL | -16.46% | $39.63B | +29.15% | 3.31% |
| SBAC | -16.29% | $25.65B | +26.32% | 1.76% |
| VZ | -16.18% | $184.17B | +6.28% | 6.15% |
SeekingAlpha
Aldeyra Therapeutics: Pivotal FDA Decision After Reproxalap's Chamber Data
Yahoo
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively trad
Finnhub
Aldeyra Therapeutics, Inc. announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration for ADX-2191 , an investigational drug candidate, for the...
Yahoo
LEXINGTON, Mass., June 26, 2025--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and Drug Administration (FDA) for ADX-2191 (methotrexate injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL), a rare and potentially fatal cancer currently lacking FDA-approved therapy.
Yahoo
LEXINGTON, Mass., June 17, 2025--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune‑mediated and metabolic diseases, today announced the resubmission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for topical ocular reproxalap, an investigational new drug candidate, for the treatment of signs and symptoms of dry eye disease. Per FDA agreement, the only new
Yahoo
As the U.S. stock market experiences a rally fueled by optimism over U.S.-China trade talks and robust corporate earnings, investors are increasingly exploring diverse investment opportunities. Penny stocks, a term that may seem outdated yet remains relevant, represent shares of smaller or newer companies that can offer significant growth potential when backed by strong financial health. In this article, we will explore several penny stocks that demonstrate balance sheet strength and...
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| FC | 51.90% | $313.13M | -36.95% | 0.00% |
| RXST | 50.92% | $533.16M | -77.00% | 0.00% |
| SN | 42.79% | $13.93B | +31.96% | 0.00% |
| RGP | 42.25% | $190.48M | -44.72% | 8.48% |
| LOGI | 42.25% | $13.51B | -3.61% | 1.50% |
| VSH | 42.07% | $2.18B | -26.91% | 2.46% |
| LFUS | 41.36% | $5.71B | -7.97% | 1.21% |
| RH | 40.61% | $3.73B | -20.25% | 0.00% |
| HVT | 40.39% | $349.39M | -10.88% | 5.89% |
| GAP | 39.57% | $8.38B | -2.35% | 2.77% |
| W | 39.55% | $6.67B | +0.87% | 0.00% |
| CGON | 38.37% | $2.01B | -15.87% | 0.00% |
| ETD | 38.33% | $746.37M | +7.71% | 5.34% |
| ICHR | 37.96% | $719.25M | -46.83% | 0.00% |
| SCVL | 37.83% | $556.28M | -43.71% | 2.74% |
| TPG | 37.73% | $7.29B | +28.47% | 3.29% |
| RL | 37.42% | $16.49B | +61.25% | 1.25% |
| VPG | 37.40% | $374.79M | -5.39% | 0.00% |
| HAYW | 37.00% | $3.06B | +17.12% | 0.00% |
| DIOD | 37.00% | $2.57B | -23.21% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| AGGH | -0.04% | $322.91M | 0.29% |
| IGF | -0.06% | $7.40B | 0.42% |
| BKAG | -0.13% | $1.90B | 0% |
| MMIT | 0.14% | $1.03B | 0.3% |
| BNDX | -0.16% | $67.49B | 0.07% |
| FISR | -0.16% | $428.82M | 0.5% |
| AAAU | 0.18% | $1.54B | 0.18% |
| VMBS | -0.21% | $14.44B | 0.03% |
| GOVI | 0.22% | $923.46M | 0.15% |
| SGOL | 0.24% | $5.14B | 0.17% |
| UITB | -0.26% | $2.33B | 0.39% |
| BSCS | -0.26% | $2.62B | 0.1% |
| OUNZ | 0.28% | $1.74B | 0.25% |
| FXU | -0.29% | $1.65B | 0.64% |
| GLDM | 0.32% | $15.61B | 0.1% |
| FEMB | -0.34% | $163.16M | 0.85% |
| GDXJ | -0.35% | $5.34B | 0.51% |
| IBHE | -0.36% | $553.15M | 0.35% |
| NFRA | -0.37% | $2.72B | 0.47% |
| ACWV | -0.39% | $3.32B | 0.2% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| IWMY | 37.77% | $118.77M | 1.02% |
| IWC | 37.04% | $817.74M | 0.6% |
| VNM | 36.55% | $420.54M | 0.68% |
| CPRJ | 35.72% | $48.21M | 0.69% |
| IAT | 35.41% | $632.05M | 0.4% |
| PRFZ | 35.28% | $2.36B | 0.34% |
| IWM | 35.21% | $63.18B | 0.19% |
| XRT | 35.20% | $309.43M | 0.35% |
| VTWO | 35.18% | $12.58B | 0.07% |
| DFSV | 35.15% | $4.69B | 0.3% |
| GSSC | 35.09% | $560.96M | 0.2% |
| FXD | 35.06% | $319.74M | 0.61% |
| VIOV | 35.05% | $1.27B | 0.1% |
| IWN | 35.03% | $10.93B | 0.24% |
| SCHA | 34.96% | $17.26B | 0.04% |
| IWO | 34.65% | $11.53B | 0.24% |
| XTN | 34.60% | $172.19M | 0.35% |
| SPSM | 34.53% | $11.31B | 0.03% |
| EES | 34.49% | $584.75M | 0.38% |
| FYX | 34.47% | $820.40M | 0.6% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -42.86% | $295.67M | 1.43% |
| VIXY | -30.84% | $165.58M | 0.85% |
| IVOL | -23.83% | $348.25M | 1.02% |
| NEAR | -21.98% | $3.34B | 0.25% |
| STIP | -21.80% | $12.70B | 0.03% |
| TAIL | -20.98% | $99.49M | 0.59% |
| VTIP | -20.96% | $15.34B | 0.03% |
| STPZ | -19.74% | $450.05M | 0.2% |
| TDTT | -18.78% | $2.63B | 0.18% |
| FXC | -18.74% | $93.05M | 0.4% |
| IYK | -17.88% | $1.45B | 0.4% |
| DFNM | -16.27% | $1.57B | 0.17% |
| MEAR | -15.86% | $1.13B | 0.25% |
| SCHO | -15.41% | $11.46B | 0.03% |
| VUSB | -15.31% | $5.35B | 0.1% |
| VGSH | -14.56% | $22.77B | 0.03% |
| SHY | -14.27% | $23.96B | 0.15% |
| CARY | -14.01% | $347.36M | 0.8% |
| IBTF | -12.95% | $2.02B | 0.07% |
| FXY | -12.84% | $820.31M | 0.4% |
